Table 3.
Outcome variables (n = 302, 6 missing and not included because of incomplete data with respect to the timing of AT resumption)
| Early resumption (N = 100) | Late resumption (N = 202) | P value | |
|---|---|---|---|
| Reoperation, n (%) | 7 (7.0) | 28 (13.9) | 0.08 |
| Time to reoperation or bleeding event, n(%) | 0.40 | ||
| < 1 month | 5 (71.4) | 13 (46.4) | |
| 1–2 months | 2 (28.6) | 11 (39.3) | |
| 2–6 months | 0 | 4 (14.3) | |
| Thromboembolic event, n (%) | 2 (2.0) | 22 (11.0) | <0.01 |
| Myocardial | 1 (1.0) | 6 (3.0) | |
| TIA | 0 (0.0) | 7 (3.5) | |
| Stroke | 0 (0.0) | 5 (2.5) | |
| Pulmonary embolism | 0 (0.0) | 3 (1.5) | |
| Deep vein thrombosis | 1 (1.0) | 3 (1.5) | |
| Peripheral/other | 0 | 1 (0.5) | |
| Time to thromboembolism, n (%) | 0.52 | ||
| < 1 month | 1 (50.0) | 14 (63.6) | |
| 1–2 months | 1 (50.0) | 4 (18.2) | |
| 2–6 months | 0 | 4 (18.2) | |
| Event-based resumption within 30 days | NA | 10 (20.2) | NA |
| Complication, n (%) | 7 (7.0) | 29 (14.4) | 0.06 |
| Landriel Ibanez grade ≥ 2, n (%) | 3 (3.0) | 16 (7.9) | 0.10 |
| Mortality | |||
| 30-day mortality, n (%) | 1 (1.0) | 11 (5.5) | 0.06 |
| 90-day mortality, n (%) | 4 (4.0) | 14 (7.0) | 0.31 |